Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Teva Pharmaceutical Industries Limited - Depositary ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

Fintel reports that on June 6, 2025, Goldman Sachs upgraded their outlook for MasTec (NYSE:MTZ) from Neutral to Buy. Analyst ...

Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's ...

Goldman Sachs suggests hedging with gold and positioning for dollar weakness against major currencies. Markets have turned ...

Elon Musk has alienated “multiple sides of the political spectrum” from Tesla, according to one prominent Wall Street analyst ...

Investing.com -- Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva ...

Delayed investment returns intensify liquidity pressures at endowments, pension funds and family offices — a key investment bloc for the private equity industry. It has driven such investors, known as ...

Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) is a passively managed exchange traded fund ...

Goldman Sachs BDC in its Q1'25 reported an improved balance sheet, new dividend flexibility, 17% NAV discount, and rebound ...